You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Article metrics

Article menu

Download PDFPDF

Immunotherapy biomarkers
Original research
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

 

Online download statistics by month:

Online download statistics by month: March 2022 to August 2025

AbstractFullPdf
Mar 202211881228482
Apr 2022670692153
May 2022525545152
Jun 202229530682
Jul 202234835347
Aug 2022389395124
Sep 2022380383105
Oct 202229930356
Nov 202229229470
Dec 202230931056
Jan 202325025351
Feb 202329529659
Mar 202324724766
Apr 202319019054
May 202320220331
Jun 202323123165
Jul 202319420046
Aug 202314614651
Sep 202311311328
Oct 202311711738
Nov 202313613629
Dec 202311711829
Jan 2024838349
Feb 2024747429
Mar 202414314387
Apr 202412612751
May 202411111134
Jun 202410811025
Jul 202413013044
Aug 20241009925
Sep 2024737440
Oct 2024979737
Nov 202414114256
Dec 202413914031
Jan 202510810946
Feb 202514714732
Mar 2025969630
Apr 202510710730
May 2025909130
Jun 2025717114
Jul 2025110
Aug 2025110
Total887990122564